Scantox Ballerup ApS: Financial statements 2019
CVR: 34724938
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Scantox Ballerup ApS (CVR 34724938) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 6,658,114 and a net result of DKK 829,966 compared with DKK -194,840 the year before. That is an increase of 36.4% compared with the year before. Equity in the 2019 report amounted to DKK 4,822,291. The solvency ratio was 72.5%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 6,658,114
- Profit/Loss
- DKK 829,966
- Equity
- DKK 4,822,291
- Total Assets
- DKK 6,649,402
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 6.7M | 830K | 4.8M | 7 |
| 2018 | - | 4.9M | -195K | 4.1M | 7 |
| 2017 | - | 10.3M | 3.8M | 4.3M | 6 |
| 2016 | - | 8.5M | 1.8M | 4.1M | - |
| 2015 | - | 8.7M | 3.6M | 2.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Scantox Ballerup ApS has published its annual report for 2018. Gross profit came to DKK 4,880,154, and the net result was DKK -194,840.
About Scantox Ballerup ApS
Scantox Ballerup ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SOLURAL PHARMA ApS. The management consists of Helle Kirstein Erichsen. The board consists of Jeanet Løgsted Nielsen (chair) and Emil Staal Bergander. The company is owned by Scantox Denmark ApS. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. Equity in the 2025 report amounted to DKK -1,539,321.